Salzmann Peter's Form 4 filing
Immunovant, Inc. (IMVT) · filed Nov 24, 2023
- Accession no.
- 0001764013-23-000146
- Filed
- Nov 24, 2023
- Trade date
- Nov 22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $531.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salzmann PeterCIK 0001796309 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | Common Stock | SSaleDisposed | −15,601 | $32.75 | −$510,932.75 | 949,125 | Direct | |
| Nov 22, 2023 | Common Stock | SSaleDisposed | −616 | $33.52 | −$20,648.32 | 948,509 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.